Translation initiator EIF4G1 mutations in familial Parkinson disease.

[1]  M. Farrer,et al.  VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.

[2]  J. Hardy,et al.  Genetic Analysis of Pathways to Parkinson Disease , 2010, Neuron.

[3]  N. Sokol,et al.  Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression , 2010, Nature.

[4]  Thomas Gasser,et al.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.

[5]  A. Whitworth,et al.  Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss , 2009, Nature Neuroscience.

[6]  H. Büeler Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease , 2009, Experimental Neurology.

[7]  P. Greengard,et al.  Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l-DOPA–Induced Dyskinesia , 2009, Science Signaling.

[8]  H. Braak,et al.  Parkinson's Disease , 2009, Annals of the New York Academy of Sciences.

[9]  P. Levine,et al.  Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer , 2009, Nature Cell Biology.

[10]  J. Blenis,et al.  Molecular mechanisms of mTOR-mediated translational control , 2009, Nature Reviews Molecular Cell Biology.

[11]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[12]  N. Sonenberg,et al.  Requirement of RNA Binding of Mammalian Eukaryotic Translation Initiation Factor 4GI (eIF4GI) for Efficient Interaction of eIF4E with the mRNA Cap , 2008, Molecular and Cellular Biology.

[13]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[14]  J. Zavadil,et al.  eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy , 2008, The Journal of cell biology.

[15]  G. Scheper,et al.  Translation matters: protein synthesis defects in inherited disease , 2007, Nature Reviews Genetics.

[16]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[17]  Aaron K. LeFebvre,et al.  Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit* , 2006, Journal of Biological Chemistry.

[18]  Tara Cox Matise,et al.  MAP-O-MAT: internet-based linkage mapping , 2005, Bioinform..

[19]  J. Darlix,et al.  Conducting the initiation of protein synthesis: the role of eIF4G , 2003, Biology of the cell.

[20]  D E Weeks,et al.  Multipoint Estimation of Identity-by-Descent Probabilities at Arbitrary Positions among Marker Loci on General Pedigrees , 2001, Human Heredity.

[21]  L. Defebvre,et al.  Linkage exclusion in French families with probable Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[22]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[23]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[24]  J. Ott Computer-simulation methods in human linkage analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.